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Abstract
The N-terminal domain of HIV-1 glycoprotein 41 000 (FP; residues 1^23; AVGIGALFLGFLGAAGSTMGARSCO-
NH2) participates in fusion processes underlying virus^cell infection. Here, we use physical techniques to study the secondary
conformation of synthetic FP in aqueous, structure-promoting, lipid and biomembrane environments. Circular dichroism
and conventional, 12C-Fourier transform infrared (FTIR) spectroscopy indicated the following K-helical levels for FP in
1-palmitoyl-2-oleoylphosphatidylglycerol (POPG) liposomesVhexafluoroisopropanol (HFIP)s trifluoroethanol (TFE) -
s phosphate-buffered saline (PBS). 12C-FTIR spectra also showed disordered FP structures in these environments, along
with substantial L-structures for FP in TFE or PBS. In further experiments designed to map secondary conformations to
specific residues, isotope-enhanced FTIR spectroscopy was performed using a suite of FP peptides labeled with 13C-carbonyl
at multiple sites. Combining these 13C-enhanced FTIR results with molecular simulations indicated the following model for
FP in HFIP: K-helix (residues 3^16) and random and L-structures (residues 1^2 and residues 17^23). Additional 13C-FTIR
analysis indicated a similar conformation for FP in POPG at low peptide loading, except that the K-helix extends over
residues 1^16. At low peptide loading in either human erythrocyte ghosts or lipid extracts from ghosts, 13C-FTIR
spectroscopy showed K-helical conformations for the central core of FP (residues 5^15); on the other hand, at high peptide
loading in ghosts or lipid extracts, the central core of FP assumed an antiparallel L-structure. FP at low loading in ghosts
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probably inserts deeply as an K-helix into the hydrophobic membrane bilayer, while at higher loading FP primarily associates
with ghosts as an aqueous-accessible, L-sheet. In future studies, 13C-FTIR spectroscopy may yield residue-specific
conformations for other membrane-bound proteins or peptides, which have been difficult to analyze with more standard
methodologies. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The amino-terminal peptide (FP; amino acids 1^
23; Fig. 1) of glycoprotein 41 000 (gp41) has been
proposed to be involved in the fusion activities
underlying human immunode¢ciency virus (HIV-1)
infection of target cells [1]. In myxoviruses and para-
myxoviruses, the fusion domain is a conserved hy-
drophobic amino acid sequence at the N-terminus of
the viral envelope F1 protein [2]. Gallaher [3] and
Gonzalez-Scarano et al. [4] each observed extensive
homologies of these sequences with those of the
N-terminus of gp41, and suggested that the N-termi-
nal gp41 peptide participates in the fusion of the
HIV-1 envelope with host cells. When the HIV-1
glycoprotein 120 000 (gp120) binds to the lymphocyte
CD4 receptor and one of several coreceptors of the
chemokine family, the N-terminal gp41 domain is
activated, which in turn may attack the target cell
surface [2,5]. Recent physical studies [6^14] were in-
terpreted as indicating that HIV-1 gp41 has a multi-
meric protein core that presents the N-terminal pep-
tide as a trimer, similar to the low-pH-induced
conformation of in£uenza virus hemagglutinin pro-
tein (HA2) [15]. These ¢ndings suggest that gp41
shares aspects of the low-pH-induced ‘spring-loaded’
mechanism for HA2, in which the N-terminal fusion
peptide undergoes a major translocation [15,16]. Ac-
cording to one model, the N-terminus of HIV-1 gp41
inserts deeply into the host cell surface membrane
[17], and the viral envelope gp41 couples the target
cell surface to the HIV-1 lipid bilayer [18,19].
Experimental evidence has now accumulated con-
¢rming the participation of the N-terminal gp41 do-
main in HIV-1 mediated cytolytic and fusogenic pro-
cesses. For example, site-directed mutagenesis studies
indicated defective gp41 fusion activity for various
modi¢cations in the N-terminal domain, including
substitutions of hydrophobic amino acids with polar
residues [20^24], deletion of short amino acid sequen-
ces [25], or replacement of highly conserved Gly or
Phe residues with Val [26,27]. A separate experimen-
tal approach has been to synthesize peptides based
on the known N-terminal gp41 sequence, and then to
determine whether the biological activity attributed
to the peptide domain in the virus is also observed
with the isolated peptide. For example, synthetic
peptides based on the N-terminal domain of gp41
induced leakage of lipid vesicles [28^36], supporting
the proposal that the N-terminus of gp41 is partly
responsible for the cytolytic actions of whole HIV-1
virions. In agreement with this hypothesis is the ¢nd-
ing that FP lysed both CD4 (cultured Hut-78 lym-
phocytes) and CD43 (human erythrocytes) cells
[37,38]. Addition of N-terminal gp41 peptides to
model liposomes also promoted lipid mixing [27^
29, 31^34, 39^41]. With human erythrocytes, FP
not only triggers rapid lipid mixing between cell
membranes, but also induces multicell aggregates
[38,42,43]. Of particular interest are the observations
that selective modi¢cations in synthetic N-terminal
gp41 peptides reduced cytolytic and fusogenic activ-
ities, in parallel with the depressed syncytia-forming
properties of the corresponding mutated full-length
gp41 [27,33,35,39,40,42,43]. Furthermore, anti-HIV
agents which block the membrane actions of the
N-terminal gp41 peptide also reduce viral-mediated
fusion [38,44^46]. Collectively, the above results sug-
gest that critical fusogenic actions of HIV-1 gp41 are
captured by synthetic N-terminal peptides.
Given the likely participation of the N-terminal
gp41 region in HIV-1 fusion, it is important to elu-
cidate the structure of this domain in membrane en-
vironments. The preferred approach would be to de-
termine its three-dimensional structure using X-ray
crystallography. However, previous X-ray analyses
have been performed only on gp41 proteins lacking
the N-terminal region, because full-length gp41 pro-
teins do not form crystals [10^12,47]. Instead, circu-
lar dichroism (CD) and Fourier transform infrared
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(FTIR) spectroscopy have been used to study the
conformation of synthetic N-terminal gp41 peptides.
These techniques indicated that N-terminal gp41
peptides assume variable proportions of K-helix,
L-sheet, L-turn and random conformations when in
structure-promoting solvents and membrane-mimics,
depending on peptide length and concentration, sol-
vent polarity, lipid charge and cation concentrations
[17,28,29,31^35,39^41,43,48^53]. Furthermore, ori-
ented FTIR spectra of the N-terminal gp41 peptide
indicated an oblique insertion of the K-helix region
into lipid bilayers [31,39]. Nevertheless, an important
limitation of this earlier work is that CD and con-
ventional FTIR spectroscopy are global methodolo-
gies that cannot assign conformations or orientations
to individual amino acid residues within the peptide.
Accordingly, several ‘residue-speci¢c’ techniques
have been performed to de¢ne the conformation of
N-terminal gp41 peptides in membrane-mimics. For
example, CD spectra of FP and a series of truncated
FP peptides in hexa£uoroisopropanol (HFIP):H2O
(7:3, v/v) indicated an K-helical conformation for
residues Ala-1 through Gly-13 [43]. Since amino
acids that participate in de¢ned secondary structure
(i.e. K-helix or L-sheet) exchange amino hydrogens
more slowly than residues in random structures, deu-
terium exchange followed by mass spectrometry was
combined with CD spectroscopy to also map confor-
mations to speci¢c FP residues [51]. This joint anal-
ysis indicated that residues Gly-5 through Ala-15
were K-helical for FP in 70% HFIP, while only res-
idues Leu-9 through Ala-15 were K-helical in the less
structure-promoting solvent 50% tri£uoroethanol
(TFE) [51]. In a two-dimensional nuclear magnetic
resonance (2D-NMR), CD and molecular modeling
study of FP suspended in either TFE solvent or so-
dium dodecyl sulfate (SDS) detergent, Chang et al.
[48,49] observed high levels of K-helix. Speci¢cally,
FP in 50% TFE assumed an K-helix conformation
for residues Ile-4 to Ala-15, whereas the correspond-
ing K-helix included residues Gly-5 to Gly-16 for FP
bound to SDS micelles. With a 2D-NMR investiga-
tion of a FP analog in SDS, Vidal et al. [50] similarly
reported that the hydrophobic core (Vresidues Gly-
5 to Gly-16) folded in an K-helical conformation.
However, caution must be employed in extrapolating
these structural ¢ndings for N-terminal gp41 peptides
in membrane-mimics to FP in membrane lipids. Ex-
periments using truncated peptides to localize sec-
ondary structure such as Mobley et al. [43] introduce
uncertainty, because shortened peptides may arti¢-
cially fray at their unprotected N- and C-terminal
ends. Moreover, the local FP conformations deter-
mined above in membrane-mimics (e.g. HFIP, TFE
and SDS) may not faithfully re£ect the correspond-
ing structure in lipid bilayers.
Because of the inherent limitations of using mimics
to simulate membrane environments, it is important
to more directly assess the residue-speci¢c conforma-
tion of FP in lipids and biological membranes using
alternative experimental methodologies. In this ar-
ticle, we study the structure of the N-terminal
HIV-1 gp41 peptide (FP) in phosphate-bu¡ered sa-
line (PBS), the membrane-mimic HFIP or TFE, or
the lipid 1-palmitoyl-2-oleoylphosphatidylglycerol
(POPG) using CD and conventional 12C-FTIR spec-
troscopy. Additional FTIR experiments were con-
ducted using a suite of 13C-labeled FP to determine
the residue-speci¢c conformations of FP in the above
membrane-mimic and lipid environments, and also
erythrocyte ghosts and ghost lipid extracts. Earlier
13C-FTIR spectroscopic investigations have indicated
the versatility of this approach, demonstrating spe-
ci¢c random, L-strand, L-turn and K-helical domains
in soluble peptides [54,55], antiparallel L-sheet struc-
tures in amyloid peptides [56^58], K-helical coiled
coils in model peptides [59], K-helix and orientation
for discrete regions in the transmembrane domains of
either phospholamban [60] or HIV-1 vpu [61], and
K-helical regions in the transmembrane domain of
in£uenza hemagglutinin [62]. Isotope-enhanced 13C-
FTIR spectroscopy has been previously combined
with energy minimizations and molecular simulations
to provide a comprehensive model of the N-terminal
peptide of human surfactant protein B (SP-B1ÿ25)
in POPG lipid, which speci¢ed locations for L-sheet,
K-helix and random conformations [63]. Here we
employ 13C-FTIR techniques to examine in
detail the polymorphic conformations that FP
exhibits in membrane-mimic, model lipid bilayers,
and human erythrocyte ghosts and ghost lipid ex-
tracts.
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2. Materials and methods
2.1. Materials
Peptide synthesis reagents, included Fmoc amino
acids and coupling solvents, were obtained from Ap-
plied Biosystems (Foster City, CA, USA). Deuterium
was supplied by Aldrich (Milwaukee, WI, USA).
Deuterated HFIP, TFE, and formic acid were ob-
tained from Cambridge Isotope Laboratories (And-
over, MA, USA). Fmoc 13C-carbonyl alanine, gly-
cine, leucine, and phenylalanine were purchased
from Cambridge Isotope Laboratories. 13C-Carbonyl
phenylalanine was converted to the Fmoc derivative
by AnaSpec (San Jose, CA, USA). POPG was ob-
tained from Avanti Polar Lipids (Alabaster, AL,
USA). R18, octadecyl rhodamine B, was from Mo-
lecular Probes (Eugene, OR, USA). All organic sol-
vents used for sample synthesis, puri¢cation and
preparation were high performance liquid chroma-
tography (HPLC) grade or better.
2.2. Solid-phase peptide synthesis, puri¢cation and
characterizations
The 23-amino acid N-terminal sequence of gp41
(FP; Fig. 1) of the HIV-1 strain LAV1a was prepared
with either an ABI 431A peptide synthesizer or a
Fig. 1. Amino acid sequences of the native N-terminal peptide (FP) of HIV-1 gp41, and seven FP variants labeled with 13C at distinct
positions. The N-terminal gp41 peptide is from the HIV-1 strain LAV1a with the sequence 1^23, corresponding to residues 519^541
using the numbering of Myers et al. [64]. Amino acids are represented by one-letter codes, and those residues labeled with 13C-carbon-
yls are indicated with bolded letters and asterisks.
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Protein Technologies Symphony/Multiplex SPPS
synthesizer, and puri¢ed by reverse phase HPLC as
described earlier [45]; FP encompasses amino acid
residues 519^541 of HIV-1 gp41 [64]. The following
13C-carbonyl enhanced FP analogues were similarly
prepared: FPA1=G3, FPA1=G3=G5=L7, FPG5=A6,
FPG5ÿA16, FPL7=L9=L12, FPG13ÿG16 and FPG20=A21
(Fig. 1). After HPLC puri¢cation, the peptides
were twice freeze-dried from 0.01 M HCl to remove
any residual acetate counterions that might interfere
with FTIR measurements. The expected molecular
masses of FP and isotope-enhanced FP analogues
were obtained by fast-atom bombardment (FAB)
and electrospray ionization (ESI) mass spectrometry
(UCLA Center for Molecular and Medical Sciences
Mass Spectrometry). Quantitative amino acid com-
positions for the peptides were determined at the
UCLA Protein Microsequencing Facility.
2.3. Rationale for 13C-site-directed FP substitutions
To probe the secondary conformations within FP,
FTIR spectroscopy was conducted with site-directed,
isotope-enhanced peptides. Speci¢cally, 13C-carbonyl
groups were incorporated into multiple, neighboring
amino acid residues of synthetic FP peptides (Fig. 1).
Separate peptides were prepared with ‘cassettes’ of
multiply 13C-enhanced substitutions that were stag-
gered to sequentially cover the peptide (Fig. 1). In
earlier studies [54,55,60^63], cassettes of similarly
13C-enhanced peptides permitted local domain map-
ping of various secondary conformations (e.g. K-he-
lix, L-sheet, L-turn and random). The principal ra-
tionale behind these experiments is that the
secondary structure with a peptide (or protein) usu-
ally extends over more than several adjacent residues
[65].
2.4. Preparation of POPG liposomes for
spectroscopic studies
Large unilamellar vesicles (LUV) of POPG in PBS
(120 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, pH
7.4) were prepared by extrusion through polycarbon-
ate ¢lters [66]. A dry lipid ¢lm was hydrated with
bu¡er-saline solution, followed by vortexing of the
dispersion to form multilamellar vesicles. The sus-
pension was freeze thawed ¢ve times, and then ex-
truded through 100 nm pore size polycarbonate ¢l-
ters (Nuclepore, Pleasanton, CA, USA) ¢ves times
using a LipoFast device (Avestin, Ottawa, ON, Can-
ada). The size distribution of extruded unilamellar
vesicles was determined by dynamic light scattering
with a Microtrac 9230 UPA ultra¢ne particle ana-
lyzer (Leeds and Northrup, St. Petersburg, FL,
USA) [67]. Extrusion through the 100 nm pore ¢lters
yielded a single population of POPG vesicles with a
mean diameter of 95.8 nm and a standard deviation
of 20.3 nm. LUV were suspended at 500 nmoles lip-
id/ml PBS bu¡er for spectroscopic studies.
2.5. Preparation of human erythrocyte ghosts and
lipid extracts from erythrocyte ghosts
Ghosts were isolated from human erythrocytes,
obtained from outdated units from the local Blood
Bank [68] and suspended in the isotonic PBS bu¡er.
Lipids were extracted by incubating ghosts with iso-
propanol [69]. The lipid extract was concentrated by
low-temperature, low-pressure rotary evaporation.
Lipid phosphorus was quanti¢ed as described earlier
[17].
2.6. CD spectroscopy
CD measurements were made with an AVIV 62DS
spectropolarimeter (AVIV Associates, Lakewood,
NJ, USA), ¢tted with a thermoelectric controller
that maintained the same temperature at 25‡C
[63,70,71]. Peptide solutions or peptide:liposome sus-
pensions were measured in 0.1 mm light path de-
mountable cells scanned from 250 to 185 nm at a
rate of 10 nm/min and a sample interval of 0.2 nm.
The instrument was routinely calibrated with (+)-10-
camphorsulfonic acid (1 mg/ml) and a 1 mm path
length cell [72], and the ellipticity expressed as the
mean residue ellipticity, [3]MRE (deg cm2 dmol31).
Peptide sample concentrations were determined
from quantitative amino acid analysis (UCLA Mi-
crosequencing Facility).
The K-helical structure of FP peptides in solvent or
lipid environments was determined from CD spectra
with the following methodology. The percentage of
K-helical conformation in the peptide was estimated
using the formalism of Chen et al. [73]. This ap-
proach assumes the maximum theoretical ellipticity
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for a given peptide or protein at 222 nm may be
derived from the number of amino acid residues
(n), and the ellipticity at 222 nm of a helix of in¢nite
length described by Eq. 1:
% Kÿ helix 
3 MRE=339500132:57=ndeg cm2 dmol31 1
2.7. FTIR spectroscopy
Infrared spectra were recorded at 25‡C using either
a Mattson Series FTIR spectrometer (Drew Univer-
sity) or Bruker Vector 22 FTIR spectrometers (Cal-
ifornia State Polytechnic University, Pomona and
Harbor-UCLA REI) equipped with DTGS detectors,
averaged over 256 scans at a gain of 4 and a resolu-
tion of 2 cm31 [43,63,70]. For FTIR spectra of FP
originally in solvents, peptide self-¢lms were pre-
pared by air drying peptide solutions in 100%
HFIP onto 50U20U2 mm 45‡ attenuated total re-
£ectance (ATR) crystals ¢tted for either the Bruker
(Pike Technologies, Madison, WI, USA) or Mattson
(Spectral Solutions, Canyon, CA, USA) spectrome-
ters. The dried peptide self-¢lms were then overlaid
with solution containing deuterated solvents (i.e.
deuterated HFIP:water:formic acid (70:30:0.1, v/v),
TFE:water:formic acid (50:50:0.1, v/v) or PBS (pH
7.4)) prior to spectral acquisition; control deuterated
solvent samples were similarly prepared, but without
peptide. Spectra of FP peptides in solvent were ob-
tained by subtraction of the deuterated solvent spec-
trum from the peptide-deuterated solvent spectrum.
For measurements with peptides in a lipid environ-
ment, FP peptides were added to LUV of POPG
from 100% HFIP, and incubated with the liposomes
for 1 h. FTIR spectra were recorded on the above
unchromatographed peptide:liposome mixtures, and
also on these peptide:lipid samples after passing
through a Sephadex G-50 column to remove non-
liposome-associated peptide [31]. Chromatographed
and unchromatographed lipid^peptide samples were
dried onto the ATR crystal. POPG lipid^peptide
samples, and also control POPG lipid samples with-
out peptide, were hydrated for 2 h with nitrogen-
D2O vapor, before spectral measurement. The FP
in POPG lipid spectrum was obtained by subtracting
the POPG lipid with D2O hydration spectrum from
that of FP in POPG with D2O hydration. Peptide/
lipid (P/L) ratios were determined here using the ear-
lier ¢nding of Martin et al. [31] that the peptide
concentration is proportional to the area (Samide) of
the amide I band (1680^1600 cm31), while the lipid
concentration is proportional to the area (SXCOlipid)
of the lipid X(C = O) band (1770^1700 cm31). There-
fore, the peptide/lipid ratio is proportional to the
following ratio: (Samide)/(SXCOlipid).
FTIR spectroscopy was also performed on FP
peptides added to either human red blood cell ghosts,
or lipids extracted from ghosts. Using a concentrated
peptide^HFIP stock solution, FP was added to
ghosts suspended in 5 mM phosphate bu¡er (pH
7.0) to yield the indicated P/L ratio and a ¢nal
HFIP concentration of 3%; control ghosts were sim-
ilarly prepared but omitting peptide. FTIR spectra of
peptide in ghosts at 25‡C were obtained by subtrac-
tion of the control ghost spectrum from the corre-
sponding spectrum of peptide in ghosts with 3%
HFIP. For measurements on FP in erythrocyte lip-
ids, peptide^lipid ¢lms were prepared by air drying
an HFIP solution containing both peptides and red
blood cell (RBC) ghost lipids onto the ATR crystal
to form multilayers. The lipid^peptide sample was
then hydrated for 2 h by passing D2O vapor through
ports in the ATR attachment cover plate. Control
lipid samples were similarly prepared, but omitting
peptide. FTIR spectra of peptide in ghost lipids at
25‡C were obtained by subtraction of the ghost lipid
spectrum from the corresponding spectrum of pep-
tide in ghost lipids.
The amide I bands of conventional 12C-FTIR
spectra of FP self-¢lms and chromatographed lipid:
peptide samples were analyzed for the various sec-
ondary conformations [63,70]. For determinations
with peptide:liposomes, the spectrum of the lipid
¢lm without peptide (i.e. band centered at 1730
cm31) was subtracted from that of samples with pep-
tide associated with lipid. The proportions of K-helix,
L-turn, L-sheet and disordered conformations were
determined by Fourier self-deconvolutions for band
narrowing and area calculations of component peaks
determined with curve-¢tting software supplied by
Mattson and based on methods described by Kaup-
pine et al. [74]. The frequency limits for the di¡erent
structures were as follows: K-helix, 1662^1645 cm31,
L-sheet, 1637^1613 and 1710^1682 cm31, L-turns,
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1682^1662 cm31, and disordered or random, 1650^
1637 cm31 [75^77].
Enhancement of FP peptides with site-speci¢c 13C-
carbonyl groups permits the direct determination of
those amino acid residues participating in secondary
conformations. Since the stretching frequencies of
the peptide backbone carbonyl groups are sensitive
to local conformations, replacement of 12C with 13C
should reduce the stretching frequency of an isolated
carbonyl oscillator by V37 cm31 [54,78^80]. In the
absence of signi¢cant transition dipole coupling
(TDC) interactions [81^83], the K-helix band should
be lowered to 1625^1608 cm31, L-turns to 1645^1625
cm31 and disordered or random to 1613^1600 cm31.
These spectral shifts were detected by measuring
FTIR spectra of the natural abundance and 13C-en-
hanced peptides in various environments, and noting
the positions of any new peaks in the 13C-FTIR spec-
trum [54,60,63]. Subtle spectral shifts were also de-
tected with di¡erence FTIR spectra, obtained by sub-
tracting the natural abundance spectrum from that
of the isotopically enhanced peptide [54,63]. The dif-
ference FTIR spectra should show a negative peak at
the original position of the conformational band,
and a positive peak shifted from the original by
V37 cm31. All spectra were presented here using
Harvard ChartXL 3.0 (Serif ; http://www.harvard-
graphics.com).
2.8. Molecular modeling
The amino-terminal peptide (FP) of HIV-1 gp41
was modeled with Insight/Discover 97.0 software
(Molecular Simulations, San Diego, CA, USA) run-
ning on a Silicon Graphics Indigo-2R10000 High
Impact workstation (Beckman Research Institute
City of Hope core facility). Energy minimizations
and molecular dynamics were conducted using con-
stant valence force ¢eld (CVFF) [84,85] within the
Discover software environment. Ramachandran
plots were determined for the FP structures derived
from simulated annealing. The ¢nal re¢ned model
geometry parameters were evaluated by PRO-
CHECK [86].
2.9. Coordinates
The coordinates for the 17 lowest energy struc-
tures of FP in the HFIP solution (i.e. HFIP:
H2O:HCOOH (70:30:01, v/v)), together with a full
list of restraints, have been deposited in the Protein
Data Bank (PDB) under the accession code 1ERF.
3. Results
3.1. CD spectroscopy of FP suspended in PBS,
membrane-mimic and lipid environments
To determine the overall conformation of the
N-terminal sequence of HIV-1 gp41 (FP) in a variety
of environments, CD spectra were measured for pep-
tide in an aqueous bu¡er, two membrane-mimic sol-
vents, or a liposome suspension. CD spectra were
recorded for FP suspended in two membrane mim-
etic solvents (i.e. TFE/H2O/HCOOH (50:50:0.1, v/v)
or HFIP/H2O/HCOOH (70:30:0.1, v/v)) (not
shown). The TFE and HFIP curves each demon-
strate a characteristic double minimum at 208 and
222 nm with nearly equal negative peaks, suggesting
substantial K-helical content for FP in these environ-
ments [51]. The alternative interpretation that these
peaks re£ect 310 helix seems less likely, as recent CD
spectra with model peptides that fold as 310 helix [87]
demonstrate an unusually intense 208 nm band rela-
tive to the 222 nm band. The corresponding spec-
trum (not shown) of FP with POPG liposomes in
PBS, pH 7.4, after chromatography to remove un-
bound peptide, similarly indicates a broad double
minimum at 208 and 222 nm that is characteristic
of high K-helix. On the other hand, control CD spec-
tra with FP alone in PBS, pH 7.4, exhibited low
signal and high noise (not shown); these spectra sug-
gested a lack of K-helix and considerable random
structure for the peptide, in agreement with previous
investigations [28,88].
It is worthwhile to quantitate the secondary con-
formations of FP with further analysis of the CD
spectra. The percentage of K-helix conformation for
this peptide was estimated from Eq. 1, as described
in Section 2 [73]. This analysis demonstrated the fol-
lowing K-helical levels for FP in various environ-
ments: POPGVHFIPsTFEsPBS (Table 1). The
proportion of K-helix for FP in POPG (Table 1) in-
dicates that V13 residues participate in K-helix for
peptide incorporated into liposomes. The ¢nding of
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similar K-helical contents for FP in either POPG or
HFIP (Table 1) suggests that the HFIP solvent ac-
curately mimics the peptide environment of POPG
liposomes. It should also be noted that the K-helical
content for FP decreases in inverse proportion to the
increasing water content, in the respective HFIP,
TFE and PBS solvents. The relatively high noise
and low signal for the CD spectrum of FP in PBS
(not shown) is attributed to the formation of insolu-
ble peptide aggregates. Previous electron spin reso-
nance (ESR) studies of spin-labeled FP [45] indicated
low solubility and elevated aggregation for peptide in
PBS. Moreover, electron microscopy showed that
the N-terminal gp41 peptide 519^540 formed ¢la-
mentous, aggregated structures in aqueous medium
[30].
3.2. Conventional 12C-FTIR spectroscopy of FP in
PBS, membrane-mimic and lipid environments
The secondary conformations of FP in the above
solvent and lipid systems were next studied using
conventional 12C-FTIR spectroscopy. Representative
FTIR spectra of the amide I band for FP in the PBS,
HFIP, TFE and POPG systems are shown in Fig. 2.
A principal band occurs at 1657 cm31 for the HFIP
(Fig. 2B), TFE (Fig. 2C) and POPG (Fig. 2D) spec-
tra, consistent with high K-helical content for FP in
these membrane-mimic and lipid environments [89].
Extensive prior FTIR studies of deuterated proteins
[75,76,90,91] have assigned bands in the range 1650^
1659 cm31 as K-helical. Small low- and high-¢eld
shoulders at 1628 and 1696 cm31 also indicate sig-
ni¢cant amounts of an antiparallel L-sheet compo-
nent for FP in the TFE solvent (Fig. 2C). Contrarily,
the FTIR spectrum of FP in the PBS medium (Fig.
2A) exhibited a dominant peak at 1628 cm31, a high-
¢eld shoulder of 1643 cm31 and a minor high-¢eld
peak at 1696 cm31. The major peak at 1628 cm31
and minor peak at 1696 cm31 in Fig. 2A indicate
extensive antiparallel L-sheet for FP in PBS, created
by strong interstrand and, to a lesser degree, intra-
strand TDC interactions [81^83]; the high-¢eld
shoulder at approx. 1643 cm31 also denotes signi¢-
cant random structure for FP in PBS. Similar FTIR
spectra were observed for a range of aqueous amy-
loid peptides, and were also attributed to high pro-
portions of antiparallel L-sheet structures [56^58].
The relative proportions of secondary structure
were determined with subsequent curve ¢tting of
the above FTIR spectra, using the criteria of Byler
and Susi [75]. A typical Fourier self-deconvolution
and curve-¢tting analysis is shown for FP in the
TFE solvent (Fig. 3). In agreement with the above
CD ¢ndings (Table 1), Fig. 3 indicates that the pre-
dominant component is an K-helix (centered at 1657
cm31) for FP in TFE (Table 1). This analysis also
showed signi¢cant L-sheet (1628 and 1696 cm31
bands), L-turn (1670 cm31 band) and random (1643
Table 1
Proportions of secondary structurea for FP in solvents and
POPG lipid dispersions, as estimated from Fourier self-decon-
volution of the FTIR spectra of the peptide amide I band and
CD spectra
System % Conformation
K-Helix L-Sheet L-Turn Disordered
FTIR spectrab
HFIPc 52.0 11.5 22.5 14.1
TFEd 36.8 15.1 26.0 22.1
PBSe 19.6 32.3 23.0 25.1
POPGf 52.1 6.5 24.9 16.7
CD spectrag
HFIPh 54.3 N.D. N.D. N.D.
TFEi 35.3 N.D. N.D. N.D.
PBSj 13.0 N.D. N.D. N.D.
POPGk 58.1 N.D. N.D. N.D.
aData are the means of four separate determinations and have
an S.E. þ 5% or better.
bFTIR spectra were deconvoluted as described in Section 2
(Fig. 3).
cFP (470 WM) dried onto an ATR plate from 100% HFIP, and
resolvated with deuterated HFIP/water/formic acid (70:30:0.1,
v/v) (Fig. 2B).
dFP (470 WM) dried onto an ATR plate from 100% HFIP, and
resolvated with deuterated TFE/water/formic acid (50:50:0.1,
v/v) (Fig. 2C).
eFP (470 WM) dried onto an ATR plate from 100% HFIP, and
resolvated with deuterated PBS, pH 7.4 (Fig. 2A).
f FP incorporated into POPG at an initial P/L ratio of 1/70 for
LUV liposomes suspended in PBS, pH 7.4. Peptide/liposomes
were chromatographed to remove non-lipid-associated FP, then
dried onto the ATR plate, and resolvated with D2O (Fig. 2D).
gCD spectra were analyzed using Eq. 1 of Section 2.
hFP (47 WM) in HFIP/water/formic acid (70:30:0.1, v/v).
iFP (47 WM) in TFE/water/formic acid (50:50:0.1, v/v).
jFP (10 WM) suspended in PBS, pH 7.4.
kFP incorporated into POPG at an initial P/L ratio of 1/70 for
LUV liposomes suspended in PBS, pH 7.4. Peptide/liposomes
were chromatographed to remove non-lipid-associated FP.
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cm31 band) structures for FP in TFE (Fig. 3; Table
1). Summing each of these components yielded a
predicted FP in TFE spectrum that agreed well
with the corresponding experimental spectrum (Fig.
3). Consistent with the CD results, additional Fou-
rier self-deconvolutions of the FTIR spectra con-
¢rmed the following K-helical levels for FP in the
various environments: POPGVHFIPsTFEsPBS
(Table 1). These results are of interest, since CD
spectroscopy uses continuously solvated samples,
while ATR-FTIR spectroscopy subjects samples to
a drying and resolvation step. Our comparable ¢nd-
ings with the two spectroscopic techniques argue
against the drying and resolvation step introducing
signi¢cant experimental artifacts into the FTIR spec-
tral analysis. In parallel with the respective decreases
in K-helix conformation observed for FP in the TFE
or PBS environments, increases were noted in L- and
random structures (Table 1). These ¢ndings suggest
that moving FP from a lipid (or membrane-mimic)
milieu to a more aqueous environment transforms
certain K-helical residues into L- or random confor-
mations. Indeed, Table 1 demonstrates that L-sheet,
L-turn and random conformations assume greater
than 80% of the total secondary structure for FP in
PBS, while the corresponding K-helical content is less
than 20%.
The association of FP with POPG liposomes was
quanti¢ed by recording 12C-FTIR spectra, before
(not shown) and after chromatographing peptide:
lipid mixtures. For POPG incubated with FP at an
initial calculated P/L ratio of 1/70, the (Samide)/
(SXCOlipid) ratio for unchromatographed and chro-
matographed samples indicated s 90% peptide up-
take by liposomes. These results are consistent with
the relatively low solubility of the peptide in PBS
Fig. 3. Representative FTIR spectrum and curve ¢tting of the
amide I band of native FP in the TFE solution. Top curve is
the experimental FTIR spectrum of the amide I band, recorded
at 25‡C (see Fig. 2C). Frequency limits for di¡erent secondary
structures were as follows: K-helix, 1662^1645 cm31 ; L-sheet,
1637^1613 cm31 and 1710^1682 cm31 ; L-turn, 1682^1662
cm31 ; and disordered (random) structure, 1650^1637 cm31. The
% contributions for each component are shown in Table 1.
Overlapping the experimental spectrum is the predicted spec-
trum, obtained by summing the above components. The peptide
concentration was 470 WM, suspended in TFE/water/formic acid
(50:50:0.1, v/v).
Fig. 2. FTIR spectra of the amide I band of FP in PBS, HFIP
and TFE solutions and POPG liposomes at 25‡C, with experi-
mental conditions in Section 2. (A) FP concentration was 470
WM in deuterated PBS, pH 7.4. The arrows at 1628 and 1696
cm31 denote a L-sheet component, while the shoulder at 1643
cm31 also indicates random structure. (B) FP concentration
was 470 WM in deuterated HFIP/water/formic acid (70:30:0.1,
v/v). (C) FP concentration was 470 WM in deuterated TFE/
water/formic acid (50:50:0.1, v/v). (D) FP was added to POPG
liposomes at an initial P/L of 1/70, suspended in PBS, pH 7.4.
Peptide:liposomes were chromatographed to remove non-lipid-
associated peptide, as described in Section 2. Spectra were re-
corded on chromatographed peptide:liposomes that were dried
on the ATR and hydrated with D2O for 2 h. The arrows at
1657 cm31 in B^D indicate a dominant K-helix component for
FP in these membrane-mimic environments; there is a pro-
nounced shoulder peak at 1628 cm31 and a minor peak at 1696
cm31 in C that also indicates L-sheet structure for FP in TFE
solution. Spectra have been normalized for comparison. The ab-
scissa for each spectrum (left to right) is 1730^1580 cm31, while
the ordinate represents absorption (in arbitrary units).
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bu¡er, and a strong association between the amphi-
pathic FP and the POPG liposomes [28].
3.3. Isotopically enhanced 13C-FTIR spectroscopy of
FP in membrane-mimic and lipid environments
Although the above 12C-FTIR spectroscopic ¢nd-
ings indicate that FP assumes distinct conformations
in the HFIP, TFE, PBS and POPG systems (Figs. 2
and 3; Table 1), it is not possible using only these
data to assign secondary structure (e.g. K-helix,
L-turn, L-sheet, random) to particular residues. To
probe for local conformations, isotopically enhanced,
FTIR spectroscopy was performed with FP labeled
with 13C-carbonyls at multiple sites, staggered to se-
quentially cover the peptide (Fig. 1).
For peptides in the strongly helix-promoting HFIP
environment (Fig. 2B; Table 1), Fig. 4 shows the
natural abundance, 12C-FTIR spectrum of FP and
the isotopically enhanced 13C-FTIR spectra of FP
Fig. 4. FTIR spectra of the amide I band for the 12C-carbonyl
(i.e. ‘native’) FP peptide and a suite of multiply 13C-carbonyl-
enhanced FP peptides in HFIP solution (see Fig. 1 for amino
acid sequences). Peptides were suspended at 470 WM concentra-
tion in deuterated HFIP:water:formic acid (70:30:0.1, v/v).
Spectra were recorded at 25‡C on peptide which was ¢rst dried
on the ATR from 100% HFIP solution, and then resolvated
with deuterated HFIP:water:formic acid (70:30:0.1, v/v) (see
Section 2). (A) FPA1=G3 is the solid line and native FP is the
dashed line. The amide I band is shown for the native FP spec-
trum, with a dominant K-helical component centered at 1657
cm31. The minor peak at 1614 cm31 in the FPA1=G3 spectrum
indicates K-helical character with some disorder for Ala-1 and
Gly-3. (B) FPA1=G3=G5=L7 (solid line), FP (dashed line). The mi-
nor peak at 1619 cm31 in the FPA1=G3=G5=L7 spectrum indicates
K-helical components for Ala-1, Gly-3, Gly-5 and Leu-7. (C)
FPG5ÿA15 (solid line), FP (dashed line). The major peak at 1620
cm31 in the FPG5ÿA15 spectrum indicates a strong K-helical
component for Gly-5, Ala-6, Leu-7, Phe-8, Leu-9, Gly-10, Phe-
11, Leu-12, Gly-13, Ala-14 and Ala-15. (D) FPG20=A21 (solid
line), FP (dashed line). The minor peak at 1610 cm31 in the
FPG20=A21 spectrum indicates random (disordered) structure for
Gly-20 and Ala-21. The abscissa for each spectrum (left to
right) is 1720^1560 cm31, while the ordinate represents absorp-
tion (in arbitrary units).
Fig. 5. Di¡erence FTIR spectra of FP peptides in HFIP solu-
tion, obtained by subtracting the spectrum of the native 12C-
carbonyl FP from those of 13C-enhanced FP peptides. (A) FP
spectrum (dashed line in Fig. 4A) from FPA1=G3 (solid line in
Fig. 4A). The negative peak at 1653 cm31 (arrow), and the pos-
itive peak at 1614 cm31 and high-¢eld shoulder at 1623 cm31
(arrows) indicate a mix of K-helix and random conformations
for Ala-1 and Gly-3. (B) FP spectrum (dashed line in Fig. 4B)
from FPA1=G3=G5=L7 (solid line in Fig. 4B). The negative peak at
1657 cm31 and the positive peak at 1617 cm31 (arrows) indi-
cate K-helix conformations for Ala-1, Gly-3, Gly-5 and Leu-7.
(C) FP spectrum (dashed line in Fig. 4C) from FPG5ÿA15 (solid
line in Fig. 4C). The negative peak at 1656 cm31 and the posi-
tive peak at 1619 cm31 (arrows) indicate K-helix conformations
for Gly-5, Ala-6, Leu-7, Phe-8, Leu-9, Gly-10, Phe-11, Leu-12,
Gly-13, Ala-14 and Ala-15. (D) FP spectrum (dashed line in
Fig. 4D) from FPG20=A21 (solid line in Fig. 4D). The negative
peak at 1647 cm31 and the positive peak at 1610 cm31 (arrows)
indicate random conformations, while the negative peak at 1702
cm31 and the positive peak at 1668 cm31 denote L-sheet con-
formations, for Gly-20 and Ala-21. See Fig. 1 for amino acid
sequences of the native and 13C-enhanced FP peptides. The ab-
scissa for each spectrum (left to right) is 1720^1560 cm31, while
the ordinate represents v(absorption), in arbitrary units. The
peak-to-trough amplitudes for each spectrum were normalized.
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labeled with 13C-carbonyls at Ala-1 and Gly-3
(FPA1=G3), Ala-1, Gly-3, Gly-5 and Leu-7
(FPA1=G3=G5=L7), Gly-5 to Ala-15 (FPG5ÿA15), or
Gly-20 and Ala-21 (FPG20=A21). There are major dif-
ferences between the native and cassette FP spectra,
which are attributed to the presence of 13C-carbonyl
groups. In the FPA1=G3=G5=L7 spectrum (Fig. 4B),
there is a decrease in the area 1662^1645 cm31 cor-
responding to an K-helical component, and a concur-
rent increase in the area 1625^1608 cm31, indicating
an isotopic shift of V37 cm31. The nature of this
isotopic shift may also be visualized in a di¡erence
FTIR spectrum, obtained by subtracting the native
FTIR spectrum (dashed line in Fig. 4B) from that of
the FPA1=G3=G5=L7 spectrum (solid line in Fig. 4B);
the resulting di¡erence FTIR spectrum (Fig. 5B) con-
¢rms the presence of negative and positive bands
centered at 1657 and 1617 cm31, respectively. The
simplest interpretation of these results is that the
isotope-induced shift of V37 cm31 in Figs. 4B and
5B is due to residues Ala-1, Gly-3, Gly-5 and Leu-7
participating in K-helix (Fig. 6), a peptide conforma-
tion in which intrastrand TDC interactions will prob-
ably be negligible [56,81^83].
The conformational center of FP in the HFIP sol-
vent was similarly examined by comparing the native
FTIR spectrum with that of a FP analogue with 13C-
carbonyls at Gly-5 to Ala-15 (FPG5ÿA15). The FTIR
spectra in Fig. 4C and the di¡erence FTIR spectrum
in Fig. 5C indicate both substantial decreases in the
area 1662^1645 cm31 and correspondingly large in-
creases in the area 1625^1608 cm31, consistent with
an isotopic shift of V37 cm31. The predominant
peak at 1620 cm31 in the FPG5ÿA15 spectrum (Fig.
4C) argues that a high proportion of amino acid
residues between Gly-5 and Ala-15 probably assumes
an K-helical conformation (Fig. 6). To further test
this assignment, FTIR spectra were recorded for
FP and FPG5ÿA15 incorporated into SDS micelles
suspended in PBS at a P/L of 1/70 (not shown). Ear-
lier residue-speci¢c 2D-NMR and molecular model-
ing investigations on FP in SDS micelles (P/L of 1/
Fig. 6. Conformational map of the N-terminal peptide (FP) of HIV-1 gp41 in HFIP, TFE and POPG liposome environments, as esti-
mated from the FTIR spectra of 13C-labeled peptides. Amino acids are represented by three-letter codes. Codes (in parentheses) for
peptide conformations are: L-sheet (L), L-turn (LT), K-helix (K) and random (R). For FP (470 WM) in HFIP:water:formic acid
(70:30:0.1, v/v), secondary conformations were determined from the FTIR spectra of Figs. 4, 5 and 9. For FP (470 WM) in TFE:wa-
ter:formic acid (50:50:0.1, v/v), secondary conformations were determined from the FTIR spectra of Figs. 7 and 9. For FP with
POPG in PBS (pH 7.4) at an initial peptide/lipid ratio of 1/70, secondary conformations were determined from the FTIR spectra of
Figs. 8 and 10.
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150) demonstrated K-helix for residues Gly-5 to Gly-
16 [49]. In the present studies, 12C-FTIR spectra of
FP in SDS indicated a major peak at 1658 cm31,
while 13C-FTIR spectra of FPG5ÿA15 in SDS showed
a decrease in the peak centered at 1658 cm31 and a
new peak at 1621 cm31 (not shown), consistent with
K-helical structure for residues Gly-5 to Ala-15. Our
FTIR spectral ¢ndings agree with the prior determi-
nation of Chang et al. [49] that the center of FP in
SDS assumes an K-helical conformation. Further-
more, the similarities between the spectra of FP
and FPG5ÿA15 in SDS (not shown) with the corre-
sponding spectra of these peptides in HFIP (Fig.
4C) con¢rm that, for FP in HFIP solution, residues
Gly-5 to Ala-15 are also K-helical.
Control experiments were performed to assess
whether intermolecular TDC interactions between
13C-carbonyls contributed to the peak in the HFIP
FPG5ÿA15 spectrum at 1620 cm31 (Fig. 4C) [81^83].
The 13C-labeled FPG5ÿA15 was diluted with unlabeled
FP (i.e. 1 part 13C-peptide:1 part 12C-peptide and
1 part 13C-peptide:3 parts 12C-peptide). FTIR spec-
tra of these ‘isotopically diluted’ peptide mixtures in
the HFIP solvent indicated a reduced 13C-signal at
1620 cm31, but no frequency shift (not shown).
These FTIR results are consistent with the 1620 cm
31 peak in Fig. 4C representing a localized amide I
absorption due to K-helix.
Secondary conformations at the N- and C-termi-
nal regions of FP in the HFIP solvent were also
analyzed using FP analogues with 13C-carbonyls at
Ala-1 and Gly-3 (FPA1=G3) or Gly-20 and Ala-21
(FPG20=A21). Fig. 4D shows a small decrease in the
FPG20=A21 spectrum in the area 1658^1640 cm31 with
respect to the native FP spectrum, along with a con-
comitant increase in the area 1625^1595 cm31, sug-
gestive of a random conformation for residues Gly-
20 and Ala-21. In agreement with this assignment,
the resulting di¡erence FTIR spectrum in Fig. 5D
demonstrates a negative band centered at V1647
cm31 and a positive band at 1610 cm31, consistent
with an isotopic shift of V37 cm31 for random con-
formations. Interestingly, the di¡erence FTIR spec-
trum in Fig. 5D further shows a smaller negative
band centered atV1698 cm31 and a correspondingly
small positive band at V1668 cm31, indicative of
Gly-20 and Ala-21 simultaneously assuming limited
L-sheet conformation (Fig. 6). Multiple conforma-
tions were similarly identi¢ed for Ala-1 and Gly-3
at the extreme N-terminus of FP. Fig. 4A shows a
decrease in the FPA1=G3 spectrum in the area 1665^
1640 cm31, as well as an enhanced broad band cen-
tered at V1614 cm31. Furthermore, the correspond-
ing di¡erence FTIR spectrum (Fig. 5A) demonstrates
a large negative band centered at 1653 cm31, with a
principal positive band at 1614 cm31 and a high-¢eld
shoulder at 1623 cm31. The simplest interpretation
for the heterogeneous FPA1=G3 spectra (Figs. 4A and
5A) is that the N-terminal Ala-1 and Gly-3 residues
assume polymorphic conformations, exhibiting both
random and K-helical character (Fig. 6). The ¢nding
of multiple conformations for the carbonyl groups at
the N-terminal end of the K-helix for FP suggests
some fraying of the helix for residues Ala-1 to Gly-
3. Our inability to detect any random structures in
the FPA1=G3=G5=L7 spectra (Figs. 4B and 5B) is prob-
ably due to the high K-helical content in residues
Gly-5 and Leu-7 masking the relatively low propor-
tion of random conformation in residues Ala-1 and
Gly-3 (see below).
For peptides in the TFE solvent that produced
lower K-helix and more L-structure than the HFIP
environment (Figs. 2C and 3; Table 1), an analogous
13C-FTIR analysis was performed to localize these
secondary conformations within FP. Fig. 7B demon-
strates a decrease in the region 1685^1645 cm31 for
the FPA1=G3=G5=L7 spectrum, with new peaks centered
at 1643 and 1608 cm31, respectively. The 1643 cm31
peak in the FPA1=G3=G5=L7 spectrum (Fig. 7B) repre-
sents a shift of V37 cm31 from the native band
between 1682 and 1662 cm31 (Fig. 3), indicating
that Ala-1, Gly-3, Gly-5 and Leu-7 adopt a L-turn
conformation in the TFE environment (Fig. 6). The
additional peak in Fig. 7B centered at 1608 cm31
shows a shift of V37 cm31 from the native band
between 1650 and 1637 cm31 (Fig. 3), indicating
that Ala-1, Gly-3, Gly-5 and Leu-7 assume random
conformations in addition to the L-turn structures
(Fig. 6). FTIR spectra of FPA1=G3=G5=L7 ‘isotopically
diluted’ with native 12C-FP con¢rmed the absence of
intermolecular TDC contributions to the new 13C-
peaks at 1643 (L-turn) and 1608 cm31 (random)
peaks (not shown). Multiple conformations were
also observed in the center of FP, for peptides sus-
pended in the TFE solvent. Fig. 7C shows a marked
decrease in the region 1680^1640 cm31 for the
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FPG5ÿA15 spectrum, with a new peak at 1621 cm31
and a low-¢eld shoulder at 1592 cm31. The 1621
cm31 peak in the FPG5ÿA15 spectrum (Fig. 7C) de-
notes a shift of V37 cm31 from the native band
between 1662 and 1645 cm31 (Fig. 3), indicating
that Gly-5 through Ala-15 assume K-helix conforma-
tions in TFE (Fig. 6). The low-¢eld shoulder in Fig.
7C at 1592 cm31 is due to a shift of V37 cm31 from
the native band at 1637^1613 cm31 (Fig. 3), indicat-
ing that Gly-5 through Ala-15 adopt minor L-sheet
in addition to K-helical conformations (Fig. 6). The
similarity between the FTIR spectra of FPA1=G3 (Fig.
7A) and FPA1=G3=G5=L7 (Fig. 7B), with pronounced
peaks at 1643 and 1608 cm31, con¢rms that Ala-1
and Gly-3 simultaneously assume L-turn and random
structures in the TFE solvent (Fig. 6). The new mi-
nor peaks centered at 1634 and 1605 cm31 for the
FTIR spectrum of FPG20=A21 in TFE (Fig. 7D) also
indicate L-turn and random conformations for Gly-
20 and Ala-21 (Fig. 6).
It is important to also consider whether 13C-FTIR
Fig. 7. FTIR spectra of the amide I band for the 12C-carbonyl
(i.e. ‘native’) FP peptide and a suite of multiply 13C-carbonyl-
enhanced FP peptides in TFE solution. Peptides were sus-
pended at 470 WM concentration in deuterated TFE:water:for-
mic acid (50:50:0.1, v/v). Spectra were recorded at 25‡C on
peptide which was ¢rst dried on the ATR from 100% HFIP so-
lution, and then resolvated with deuterated TFE:water:formic
acid (50:50:0.1, v/v) (see Section 2). (A) FPA1=G3 is the solid
line and native FP is the dashed line. The amide I band is
shown for the native FP spectrum, with a dominant K-helical
component centered at 1657 cm31 and a minor peak at 1630
cm31 denoting L-sheet. The FPA1=G3 spectrum indicates broad
peaks at 1643 and 1608 cm31, denoting both L-turn and ran-
dom structure for Ala-1 and Gly-3. (B) FPA1=G3=G5=L7 (solid
line), FP (dashed line). The peaks at 1643 and 1608 cm31 in
the FPA1=G3=G5=L7 spectrum indicate L-turn and random compo-
nents for Ala-1, Gly-3, Gly-5 and Leu-7. (C) FPG5ÿA15 (solid
line), FP (dashed line). The major and minor peaks at 1621
and 1593 cm31, respectively, in the FPG5ÿA15 spectrum indicate
strong K-helical and minor L-sheet components for Gly-5, Ala-
6, Leu-7, Phe-8, Leu-9, Gly-10, Phe-11, Leu-12, Gly-13, Ala-14
and Ala-15. (D) FPG20=A21 (solid line), FP (dashed line). The
minor peaks at 1634 and 1605 cm31 in the FPG20A21 spectrum
indicate L-turn and random (disordered) structures for Gly-20
and Ala-21. The abscissa for each spectrum (left to right) is
1720^1560 cm31, while the ordinate represents absorption (in
arbitrary units).
Fig. 8. FTIR spectra of the amide I band for the 12C-carbonyl
(i.e. ‘native’) FP peptide and a suite of multiply 13C-carbonyl-
enhanced FP peptides in POPG liposomes. Peptides were sus-
pended in POPG liposomes at an initial P/L ratio of 1/70, and
chromatographed to remove unincorporated peptides as de-
scribed in Section 2. Spectra were recorded on chromato-
graphed peptide:liposomes that were dried on the ATR and hy-
drated with D2O for 2 h. (A) FPA1=G3 is the solid line and
native FP is the dashed line. The amide I band is shown for
the native FP spectrum, with a dominant K-helical com-
ponent centered at 1657 cm31. The minor peak at 1617 cm31
in the FPA1=G3 spectrum indicates K-helical character. (B)
FPA1=G3=G5=L7 (solid line), FP (dashed line). The minor peak at
1618 cm31 in the FPA1=G3=G5=L7 spectrum indicates K-helical
components for Ala-1, Gly-3, Gly-5 and Leu-7. (C) FPG5ÿA15
(solid line), FP (dashed line). The major peak at 1620 cm31 in
the FPG5ÿA15 spectrum indicates a strong K-helical component
for Gly-5, Ala-6, Leu-7, Phe-8, Leu-9, Gly-10, Phe-11, Leu-12,
Gly-13, Ala-14 and Ala-15. (D) FPG20=A21 (solid line), FP
(dashed line). The minor peak at 1611 cm31 in the FPG20=A21
spectrum indicates random (disordered) structure for Gly-20
and Ala-21. The abscissa for each spectrum (left to right) is
1720^1560 cm31, while the ordinate represents absorption (in
arbitrary units).
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spectral analysis may similarly be used to map the
local conformations of FP in an actual lipid bilayer
environment. Fig. 8B shows a decrease in the region
1670^1645 cm31 for the FPA1=G3=G5=L7 spectrum with
a new peak centered at 1618 cm31, indicating that
Ala-1, Gly-3, Gly-5 and Leu-7 are K-helical in POPG
(Fig. 6). A more marked decrease occurs in the re-
gion 1670^1640 cm31 for the FPG5ÿA15 spectrum
with a pronounced new peak centered at 1621
cm31 (Fig. 8C), indicating that Gly-5 through Ala-
15 assume K-helix conformations in POPG (Fig. 6).
Residues Ala-1 and Gly-3 at the N-terminus of FP in
POPG are also assigned as K-helix (Fig. 6), since the
13C-FTIR spectrum of FPA1=G3 (Fig. 8A) is de-
pressed in the region 1650^1660 cm31 over the native
FTIR spectrum, with a new peak at 1617 cm31. 13C-
FTIR spectroscopy also indicated that the C-termi-
nus of FP in POPG liposomes exhibited random
conformations. The new peak at 1611 cm31, along
with a depressed 1660^1640 cm31, for the FPG20=A21
spectrum (Fig. 8D) indicates that Gly-20 and Ala-21
assume random or disordered conformations in
POPG liposomes (Fig. 6). Of particular interest are
the similarities in the FTIR spectra of ‘cassette’ 13C-
labeled peptides in either the HFIP solvent (Fig. 4)
or POPG liposomes (Fig. 8), indicating that FP in
the HFIP environment accurately mimics the behav-
ior of this peptide when incorporated into lipid bi-
layers (Fig. 6).
The conformational ¢ne structure within the cen-
tral core of FP in the HFIP, TFE, and POPG envi-
ronments was further probed using fusion peptides
labeled with 13C-carbonyls at Gly-5 and Ala-6
(FPG5=A6), Leu-7, Leu-9 and Leu-12 (FPL7=L9=L12)
and Gly-13, Ala-14, Ala-15 and Gly-16 (FPG13ÿG16)
Fig. 9. FTIR spectra of the amide I band for the 12C-carbonyl
(i.e. ‘native’) FP and a suite of FP labeled with multiple 13C-
carbonyls in the central region, for peptides in the HFIP or
TFE solution. Peptides were suspended at 470 WM in deuter-
ated HFIP:water:formic acid (70:30:0.1, v/v) (A^C) or TFE:-
water:formic acid (50:50:0.1, v/v) (D^F); spectra were recorded
at 25‡C on peptide dried from 100% HFIP and resolvated on
the ATR from the respective deuterated solutions (see Section
2). (A) FPG5=A6 (solid line), FP (dashed line). The minor peak
at 1620 cm31 in the FPG5=A6 spectrum indicates K-helical com-
ponents for Gly-5 and Ala-6, for peptide in the HFIP solvent.
(B) FPL7=L9=L12 (solid line), FP (dashed line). The minor peak
at 1618 cm31 indicates K-helical components for Leu-7, Leu-9
and Leu-12 in the HFIP solvent. (C) FPG13ÿG16 (solid line), FP
(dashed line). The shoulder at 1633 cm31 represents L-turn ele-
ments for residues Gly-13, Ala-14, Ala-15 and Gly-16 in the
HFIP solvent. (D) FPG5=A6 (solid line), FP (dashed line). The
minor peak at 1600 cm31 in the FPG5=A6 spectrum indicates a
L-sheet component for Gly-5 and Ala-6, for peptide in the TFE
solvent. (E) FPL7=L9=L12 (solid line), FP (dashed line). The mi-
nor peak at 1618 cm31 indicates K-helical components for Leu-
7, Leu-9 and Leu-12 in the TFE solvent. (F) FPG13ÿG16 (solid
line), FP (dashed line). The minor peak at 1606 cm31 represents
random structure for residues Gly-13, Ala-14, Ala-15 and Gly-
16 in the TFE solvent. The abscissa for each spectrum (left to
right) is 1740^1560 cm31, while the ordinate represents absorp-
tion (in arbitrary units).
Fig. 10. FTIR spectra of the amide I band for the 12C-carbonyl
(i.e. ‘native’) FP and a suite of FP labeled with multiple 12C-
carbonyls in the central region, for peptides in POPG lipo-
somes. Peptides were suspended in POPG liposomes at an ini-
tial P/L ratio of 1/70, and chromatographed to remove unincor-
porated peptides as described in Section 2. Spectra were
recorded on chromatographed peptide:liposomes that were
dried on the ATR and hydrated with D2O for 2 h. (A) FPG5=A6
(solid line), FP (dashed line). The minor peak at 1625 cm31 in
the FPG5=A6 spectrum indicates K-helical components for Gly-5
and Ala-6, for peptide in POPG liposomes. (B) FPL7=L9=L12 (sol-
id line), FP (dashed line). The minor peak at 1618 cm31 indi-
cates K-helical components for Leu-7, Leu-9 and Leu-12 in
POPG liposomes. (C) FPG13ÿG16 (solid line), FP (dashed line).
The shoulder at 1632 cm31 represents L-turn elements for resi-
dues Gly-13, Ala-14, Ala-15 and Gly-16 in POPG liposomes.
The abscissa for each spectrum (left to right) is 1740^1560
cm31, while the ordinate represents absorption (in arbitrary
units).
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(Figs. 9 and 10). For peptides in the HFIP solvent,
the new peaks at 1620 and 1618 cm31 for the
FPG5=A6 and FPL7=L9=L12 spectra (Fig. 9A,B), respec-
tively, con¢rm that Gly-5, Ala-6, Leu-7, Leu-9 and
Leu-12 assume K-helical conformations (Fig. 6). On
the other hand, the FPG13ÿG16 spectrum (Fig. 9C) for
peptide in HFIP solvent indicates a new band at
1633 cm31, indicating that Gly-13, Ala-14, Ala-15
and Gly-16 adopt a L-turn conformation (Fig. 6);
these ¢ndings suggest that this GAAG sequence rep-
resents the C-terminal cap of the K-helix (see below).
Interestingly, the spectra of FPG5=A6, FPL7=L9=L12 or
FPG13ÿG16 (Fig. 10A^C) in POPG liposomes are very
similar to the corresponding 13C-FTIR spectra of
these analogues in the HFIP solvent (Fig. 9A^C),
verifying again that the conformation of FP in the
HFIP environment accurately mimics the structure
of this peptide in lipids. Speci¢cally, the new peaks
at 1625 and 1618 cm31 for the FPG5=A6 and
FPL7=L9=L12 spectra (Fig. 10A,B), respectively, con-
¢rm that Gly-5, Ala-6, Leu-7, Leu-9 and Leu-12
are K-helical in POPG liposomes (Fig. 6). On the
other hand, the FPG13ÿG16 spectrum (Fig. 10C) for
peptide in HFIP solvent indicates a new band at
1632 cm31, indicating that Gly-13, Ala-14, Ala-15
and Gly-16 assume a L-turn conformation in
POPG (Fig. 6). For peptides in the TFE solvent,
the FP core demonstrates signi¢cantly less K-helical
structure (Fig. 9D^F). Although a new peak at 1618
cm31 in the spectrum of FPL7=L9=L12 in TFE indicates
K-helical structure for Leu-7, Leu-9 and Leu-12 (Fig.
9E), the loss of the low-¢eld shoulder at 1630 cm31
and the extended tail to 1590 cm31 argues that these
residues concurrently exhibit L-sheet conformations
(Fig. 6). Furthermore, the FPG5=A6 in TFE spectrum
(Fig. 9D) exhibits a loss of the 1630 cm31 shoulder
and a new peak at 1600 cm31, suggesting that Gly-5
and Ala-6 adopt a L-sheet structure (Fig. 6). Last,
the FPG13ÿG16 in TFE spectrum (Fig. 9F) shows a
new peak at 1606 cm31, indicating random confor-
mations for Gly-13, Ala-14, Ala-15 and Gly-16 (Fig.
6).
3.4. Molecular modeling of FP in HFIP and POPG
lipid environments
Although the above 13C-FTIR spectroscopic anal-
ysis assigned the conformation of the majority (i.e.
70%) of the amino acids for FP in the HFIP solvent,
the conformations of a number of residues (i.e. Val-
2, Ile-4, Ser-17, Thr-18, Met-19, Arg-22, Ser-23) were
not experimentally determined. Molecular modeling
was conducted to provide structural information on
these ‘gap’ residues, and also to evaluate the confor-
mational £exibility of domains within FP. From the
13C-FTIR spectral results in Figs. 4 and 10, the ini-
tial structure was modeled as an K-helix, except for
the terminal regions (residues 1^2 and 17^23) which
were modeled as L-strands using Discover software.
Twenty cycles of simulated annealing were per-
formed, using a protocol published earlier [92], to
examine those conformations accessible to the termi-
nal regions and helix side chains. Throughout the
simulation, constraints were applied to maintain
not only the helix motif, but also the chirality of
the amino acids in the L form. Using a time step
of 0.5 fs, the system was equilibrated for 1000 iter-
ations at 300 K. The temperature was then raised to
900 K in increments of 30 K over a period of 20 ps.
Molecular dynamics was then carried out at 900 K
for 30 ps, followed by annealing to a temperature of
300 K over 50 ps. The resulting structure was then
energy minimized using 5000 steps of steepest de-
scents, followed by 10 000 steps of conjugate gra-
dients until the maximum derivative was less than
0.001. Throughout the simulation the backbone
atoms of residues 3^16 (helix) were constrained using
a force constant that increased by 25 (kcal/molUAî 2)
during each heating step. A similar torsional con-
straint was applied to all peptide bonds in order to
maintain them in the trans conformation. During the
¢nal minimization, all constraints were removed.
With the residue-speci¢c constraints based on 13C-
FTIR measurements described above, 17 molecular
models representing possible conformations of FP in
the HFIP solvent were generated by simulated an-
nealing molecular dynamics. The superimposed con-
formers are shown as stick ¢gures in Fig. 11A,
whereas a ribbon representation of a selected con-
former showing the location of each residue is indi-
cated in Fig. 11B. The geometry parameters of the
¢nal models were evaluated using PROCHECK [86].
The Ramachandran plot in Fig. 12 con¢rms that the
backbone torsion angles for all 17 conformers prin-
cipally fall within the allowed regions. Moreover, the
Ramachandran plot shows high levels of backbone
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Fig. 11. Conformation dynamic model (A) and ribbon representation (B) of the N-terminal peptide (FP) of HIV-1 gp41 in HFIP solu-
tion. (A) Superimposed view of 17 solution structures of FP, calculating from simulated annealing, molecular dynamics and geometry
optimization experiments. Constraints were imposed incorporating residue-speci¢c information derived from FTIR spectroscopy of
13C-labeled FP peptides in HFIP:water:formic acid (70:30:0.1, v/v). Conformer backbones in blue and purple indicate K-helical and
extended L-strands, respectively; side chains are denoted by purple. (B) Ribbon representation of a selected conformer showing the lo-
cation of each residue, with the same orientation as in A. Residues 3^16 encompass the K-helix (backbone shown in blue with side
chains in purple), while residues 1^2 and 17^23 are extended L-sheet (backbone and side chains shown in purple).
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torsion angles lying in the K-helix and L-structural
zones, consistent with the FP structure in the HFIP
solvent primarily subdivided into K-helix and L-con-
formations (Fig. 6; Table 1). The superimposed con-
formers (Fig. 11A) capture the major structural fea-
tures indicated by our 12C- and 13C-FTIR
spectroscopic studies, namely an K-helix (residues
3^16) and extended L- and random structures (resi-
dues 1^2 and 17^23) with a high degree of £exibility.
The fraying of the helix for residues 1^2 is consis-
tent with the intrinsic instability of K-helices at the
N-terminus, in which only the carbonyl groups for
the ¢rst four helical residues participate in the hydro-
gen-bonding network. The capping pattern at the
C-terminus of the K-helix (Fig. 11B) apparently in-
volves residues Gly-13, Ala-14, Ala-15 and Gly-16.
The above molecular model developed for FP in
the HFIP solvent may also be applied to the struc-
ture of FP in POPG liposomes, with some modi¢ca-
tions. As may be seen from 13C-FTIR spectroscopy
of FP in POPG (Fig. 6), the K-helix extends from
Ala-1 to Gly-16. Using these constraints, energy min-
imizations and molecular simulations indicated a
model for FP in POPG that was nearly identical to
that for FP in HFIP (Fig. 11A,B), except that resi-
dues Ala-1 and Val-2 also participate in the K-helix
(not shown). Similar to that found for FP in HFIP,
the molecular model for lipid FP exhibits a carboxyl
terminus for the helix, with an K-helix cap consisting
of Gly-13, Ala-14, Ala-15 and Gly-16 (not shown).
3.5. Conventional 12C- and isotopically enhanced 13C-
FTIR spectroscopy of FP in human erythrocyte
ghosts and lipid extracts from ghosts
An important remaining question focuses on
Fig. 12. Ramachandran plot [86] for the 17 best structures of the N-terminal peptide (FP) of HIV-1 gp41, derived from the simulated
annealing experiments. Psi (torsional angle for the Ca^C bond axis) is plotted versus phi (torsional angle for the Ca^N bond axis). Ini-
tial constraints were obtained from residue-speci¢c structural information derived from FTIR spectroscopy of 13C-enhanced FP pep-
tides in HFIP:water:formic acid (70:30:0.1, v/v). The dark areas represent most favored regions (A, B, L), while the light gray areas
(a, b, l, p) and lightest gray areas (Va, Vb, Vl, Vp) represent additional allowed regions. Triangles denote glycine residues.
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whether the structures determined here for HIV-1 FP
in either membrane-mimics or POPG lipids (Figs. 6
and 11A,B) bear any relevance to the conformation
of FP in biological membranes. Although previous
studies have shown that FP induces lysis, aggrega-
tion and lipid mixing of POPG liposome vesicles
[28,32], it may be argued that these negatively
charged lipid vesicles are not a good model for the
biomembranes (e.g. CD4 lymphocyte plasma mem-
branes) targeted by HIV-1. Consequently, the above
residue-speci¢c structures determined for FP in
POPG liposomes may not accurately represent FP
conformations in key membranes involved in host-
viral infections.
To address the above questions, further conven-
tional 12C-FTIR and 13C-enhanced FTIR spectrosco-
py was conducted here on FP peptides added to both
human erythrocyte ghosts and lipid extracts from
ghosts. Human red blood cell ghosts should provide
a more relevant experimental model than POPG
liposomes, because the red cell bilayer lipid compo-
sition, asymmetry and molar cholesterol/phospholip-
id (C/P) ratio approximate those in both the target
cells and the HIV-1 envelope [18]. Also it should be
noted that addition of synthetic FP to intact red
blood cells induces hemolysis, lipid mixing and ag-
gregation [37,38,42,43,45,88]. At a low P/L ratio of
1/70, conventional 12C-FTIR spectra of FP added to
human erythrocyte ghosts showed a principal band
occurring at 1655 cm31 (Fig. 13A), consistent with
high K-helical content for FP. A decrease occurs in
the region 1663^1647 cm31 for the 13C-FTIR spec-
trum of FPG5ÿA15 with a new peak centered at 1620
cm31 (Fig. 13A), con¢rming that residues Gly-5
through Ala-15 assume K-helix conformations in
ghost membranes at low peptide loading. On the
other hand, the 12C-FTIR spectrum of FP with
erythrocyte ghosts at a high P/L ratio of 1/10 (Fig.
13B) exhibited a dominant peak at 1627 cm31, and a
small high-¢eld peak at 1687 cm31, indicative of anti-
parallel L-sheet. Interestingly, the 12C-FTIR spec-
trum in Fig. 13B of high FP-loaded ghosts bears
striking similarities with that of FP in PBS (Fig.
2A), suggesting similar aqueous-accessible environ-
ments for the peptide. A decrease in absorption oc-
curs in the region 1639^1612 cm31 for the 13C-FTIR
spectrum of FPG5ÿA15 with a dominant new peak
centered at 1587 cm31 (Fig. 13B), consistent with
Gly-5 through Ala-15 folding as antiparallel L-sheet
at high peptide loading in ghosts [56].
Additional 12C- and 13C-FTIR spectroscopy was
performed to investigate both the overall structure
and residue-speci¢c conformation of FP in lipid ex-
tracts from human erythrocytes. In previous conven-
tional 12C-FTIR experiments on FP with lipid ex-
tracts from human red cells [17], a dominant peak
at 1656 cm31 was observed at a low P/L ratio of
1/200 indicating high levels of K-helix. At a higher
P/L ratio of 1/30, however, the major peak for FP in
ghost lipids was shifted to approx. 1634 cm31 and a
residual high-¢eld shoulder occurred at 1656 cm31,
consistent with the formation of extensive antiparal-
lel L-sheet coexisting with some K-helix [17]. With a
low P/L ratio of 1/70, we ¢nd here a principal band
occurring at 1656 cm31 for conventional 12C-FTIR
Fig. 13. FTIR spectra of the amide I band for the 12C-carbonyl
(i.e. ‘native’) FP peptide (dashed lines) and the 13C-carbonyl-en-
hanced FPG5ÿA15 (solid lines) in human RBC (RBC) ghosts, at
P/L ratios of 1/70 (A) or 1/10 (B). Using a concentrated pep-
tide^HFIP stock solution, FP was added to ghosts suspended
in 5 mM phosphate bu¡er (pH 7.0) to yield the indicated P/L
ratio and a ¢nal HFIP concentration of 3%; control ghosts
were similarly prepared but omitting peptide. FTIR spectra of
peptide in ghosts at 25‡C were obtained by subtraction of the
control ghost spectrum from the corresponding spectrum of
peptide in ghosts with 3% HFIP. (A) FPG5ÿA15 (solid line), FP
(dashed line), at a P/L ratio of 1/70. The amide I band is
shown for the native FP spectrum, with a dominant K-helical
component centered at 1655 cm31. The new peak at 1620 cm31
in the FPG5ÿA15 spectrum indicates an K-helical component for
Gly-5, Ala-6, Leu-7, Phe-8, Leu-9, Gly-10, Phe-11, Leu-12, Gly-
13, Ala-14 and Ala-15. (B) FPG5ÿA15 (solid line), FP (dashed
line), at a P/L ratio of 1/10. The amide I band is shown for the
native FP spectrum, with a major peak at 1627 cm31 and a mi-
nor peak at 1688 cm31 indicating a strong L-sheet component.
The new major peak at 1587 cm31 in the FPG5ÿA15 spectrum
indicates a L-sheet structure for Gly-5, Ala-6, Leu-7, Phe-8,
Leu-9, Gly-10, Phe-11, Leu-12, Gly-13, Ala-14 and Ala-15. The
abscissas for the A and B spectra (left to right) are 1720^1560
cm31 and 1720^1500 cm31, respectively, while the ordinates
represent absorption (in arbitrary units).
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spectra of FP added to lipid extracts from human
erythrocyte ghosts (Fig. 14A), in accord with high
K-helical content for FP in ghost lipids and in agree-
ment with earlier FTIR studies [17]. A large reduc-
tion occurs in the region 1674^1633 cm31 for the
FPG5ÿA15 spectrum with a major new peak centered
at 1618 cm31 (Fig. 14A), con¢rming that Gly-5
through Ala-15 assume K-helix conformations in
ghost lipids at low loading in a manner similar to
that observed for these FP peptides in either HFIP
solvent (Fig. 4C) or POPG liposomes (Fig. 8C). The
absorption shift caused by incorporation of 13C = O
for residues Gly-5 through Ala-15 is more dramatic
for ghost lipids (Fig. 14A) than ghosts (Fig. 13A),
suggesting that FP is a more tightly folded K-helix in
ghost lipids than in ghost membranes. At a high P/L
ratio of 1/10, the 12C-FTIR spectrum of FP with
ghost lipids at (Fig. 14B) showed a dominant peak
at 1624 cm31, and a small high-¢eld peak at 1686
cm31, re£ecting antiparallel L-sheet analogous to
that observed earlier [17]. A decrease in absorption
occurs in the range 1641^1608 cm31 for the FPG5ÿA15
spectrum with a predominant new peak centered at
1586 cm31 (Fig. 14B), indicating that Gly-5 through
Ala-15 fold as antiparallel L-sheet at high peptide
loading in ghost lipids. Also of interest are the com-
parable FTIR spectra of FP and FPG5ÿA15 in either
erythrocyte ghosts (Fig. 13B) or lipid extracts (Fig.
14B), suggesting equivalently high levels of antipar-
allel L-sheet for FP in these systems at high loading.
4. Discussion
The present ¢ndings highlight the utility of 13C-
enhanced FTIR spectroscopy in studying the confor-
mational £exibility of HIV-1 FP. Earlier Chou^Fas-
man analysis predicted K-helix for residues 1^18 of
FP [17], and high K-helix was con¢rmed from CD or
conventional 12C-FTIR spectra of FP in the HFIP
solvent, POPG liposomes (Fig. 2; Table 1), and hu-
man erythrocyte ghosts and lipid extracts at low pep-
tide loading (Figs. 13A and 14A). Nevertheless,
Chou^Fasman analysis did not successfully predict
the higher levels of L- and random structure in this
region observed here from CD and FTIR spectra of
FP in TFE solution, PBS (Fig. 2; Table 1), or human
erythrocyte ghosts and lipid extracts at high peptide
loading (Figs. 13B and 14B). The failure of computer
algorithms such as Chou^Fasman to predict these
structural polymorphisms emphasizes the importance
of using residue-speci¢c physical techniques. More-
over, neither CD nor conventional 12C-FTIR spec-
troscopy can provide mechanistic details on the con-
formational changes that FP undergoes, as they are
global techniques that measure only average FP con-
formations. In this study, isotope-enhanced 13C-
FTIR spectroscopy of FP permitted mapping of the
molecular changes accompanying the conversion of
K-helix to random and L-structures that occurs with
increasing water content. Under conditions of high
hydrophobicity, 13C-FTIR spectra of FP peptides in
POPG liposomes indicated K-helix for residues 1^16
(Figs. 6, 8 and 10). With the slightly more polar
HFIP solvent, both 13C-FTIR spectra (Figs. 4, 6
and 9A^C) and molecular modeling (Fig. 11A,B)
Fig. 14. FTIR spectra of the amide I band for the 12C-carbonyl
(i.e. ‘native’) FP peptide (dashed lines) and the 13C-carbonyl-en-
hanced FPG5ÿA15 (solid lines) in liposomes prepared from lipid
extracts of human RBC (RBC) ghosts, at P/L ratios of 1/70 (A)
or 1/10 (B). Peptide^lipid ¢lms were prepared by air drying an
HFIP solution containing both peptides and RBC ghost lipids
onto the ATR crystal to form multilayers. The lipid^peptide
sample was then hydrated for 2 h by passing D2O vapor
through ports in the ATR attachment cover plate. (A)
FPG5ÿA15 (solid line), FP (dashed line), at a P/L ratio of 1/70.
The amide I band is shown for the native FP spectrum, with a
dominant K-helical component centered at 1656 cm31. The new
peak at 1618 cm31 in the FPG5ÿA15 spectrum indicates a strong
K-helical component for Gly-5, Ala-6, Leu-7, Phe-8, Leu-9,
Gly-10, Phe-11, Leu-12, Gly-13, Ala-14 and Ala-15. (B)
FPG5ÿA15 (solid line), FP (dashed line), at a P/L ratio of 1/10.
The amide I band is shown for the native FP spectrum, with a
major peak at 1624 cm31 and a minor peak at 1686 cm31 indi-
cating a strong L-sheet component. The new major peak at
1587 cm31 in the FPG5ÿA15 spectrum indicates L-sheet structure
for Gly-5, Ala-6, Leu-7, Phe-8, Leu-9, Gly-10, Phe-11, Leu-12,
Gly-13, Ala-14 and Ala-15. The abscissas for the A and B spec-
tra (left to right) are 1720^1560 cm31 and 1720^1500 cm31, re-
spectively, while the ordinates represent absorption (in arbitrary
units).
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showed that the K-helix was largely conserved, except
for a partial fraying of the N-terminal Ala-1 and Val-
2 residues. 13C-FTIR spectra demonstrated that the
still more polar TFE solvent further converted FP
residues 1^7 into L- and random conformations,
and even created mixes of K-helix, L- and random
structures for the core FP residues 7^16 (Figs. 6, 7
and 9D^F). Using both CD and conventional 12C-
FTIR spectroscopy (Fig. 2A; Table 1), FP in PBS
bu¡er was observed to form extensive antiparallel
L-sheets with minimal K-helix. Our results demon-
strating that the FP conformation is sensitive to en-
vironmental polarity are broadly in agreement with
earlier 2D-NMR spectroscopic analyses of FP in
aqueous, structure-promoting solvents and SDS mi-
celles [48,49].
Conventional 12C-FTIR and 13C-enhanced FTIR
spectroscopy were also employed here to assess the
conformational changes that occur with increasing
FP concentration in erythrocyte ghosts and lipid ex-
tracts. With several exceptions [28,35], previous CD
or FTIR analyses of synthetic N-terminal gp41 pep-
tides (923 residues) with either model [28,39,43,52]
or erythrocyte ghost [17] liposomes have identi¢ed
primarily K-helix at low P/L ratios (6V1/70), and
L- and random structures at higher P/L ratios
(sV1/50). Unfortunately, the underlying mecha-
nism for this dose-dependent, conformational change
in FP remains unknown, since residue-speci¢c phys-
ical measurements were not conducted. In our stud-
ies here of either human erythrocyte ghosts or ghost
lipid extracts, 12C-FTIR spectra indicate a large K-
helical component for FP at low peptide loading
(Figs. 13A and 14A). Similar dominant K-helix con-
formations were detected for FP incorporated into
lipids at low loading, from CD or 12C-FTIR spectra
of FP with the anionic lipid POPG [28] (Fig. 2D;
Table 1), the neutral lipid egg yolk lecithin [52], mix-
tures of neutral and anionic lipids [43,49] or eryth-
rocyte ghost lipids [17]. The spectral shifts in the 13C-
enhanced FTIR spectra of FPG5ÿA15 with either
ghosts (Fig. 13A) or lipid extracts (Fig. 14A) at
low loading con¢rm that FP residues Gly-5 to Ala-
15 fold as an K-helix, and are similar to that ob-
served with POPG liposomes (Fig. 8C). The high
levels of K-helix noted for FP in either ghosts (Fig.
13A) or ghost lipids (Fig. 14A) are consistent with
deep penetration of FP into the lipid bilayer at low
loading; indeed, FP has been found to bury into the
interior of both model lipid bilayers [28,49] and hu-
man erythrocyte ghosts [17] at relatively low P/L
ratios. It should, however, be pointed out that not
all physical studies have determined signi¢cant K-he-
lix in model lipids at low FP concentrations. Conven-
tional 12C-FTIR spectra identi¢ed predominately
L-sheet for FP with either neutral 1-palmitoyl-2-
oleoylphosphatidylcholine (POPC) liposomes (P/L
ratio v 1/200) [28] or mixed dioleoylphosphatidyl-
choline/dioleoylphosphatidylethanolamine/cholesterol
vesicles (P/L v 1/800) [35]; the disparate ¢ndings ob-
tained in these studies and those above indicating
substantial K-helix at low FP loading may possibly
be due to di¡erences in the choice of lipids and sam-
ple preparation. Also of interest is the recent solid-
state 13C-enhanced NMR evidence for FP folded as
extended L-strand conformation, with peptide bound
to lipid mixtures of POPC/POPE/dimyristoyl-sn-
glycero-3-[phospho-L-serine]/cholesterol for P/L ra-
tios v 1/200 [36]. Unfortunately, NMR measure-
ments were limited to observations at 350‡C, and
independent experiments using alternative techniques
(e.g. CD or FTIR spectroscopy) were not performed
to evaluate whether the use of such low temperatures
perturbed the overall FP conformation [36].
With erythrocyte ghosts or ghost lipid extracts at
higher P/L ratios of 1/10, however, 12C-FTIR spectra
showed that FP predominantly assumes an antipar-
allel L-sheet conformation (Figs. 13B and 14B). Pri-
marily L-sheet was observed for HIV-1 FP in lipids
at high loading, from CD or 12C-FTIR spectra of FP
with the anionic lipid POPG [28], the neutral lipids
POPC [28] and egg yolk lecithin [52], mixtures of
neutral and anionic lipids [35,43,53] or erythrocyte
ghost lipids [17]. Since previous ESR experiments
with spin-labeled FP incorporated into human eryth-
rocyte ghosts indicated peptide clustering at elevated
concentrations [17], the 12C-FTIR spectral altera-
tions noted at high loading in either ghosts or ghost
lipids (Figs. 13B and 14B) are likely due to mem-
brane-bound FP aggregates. Such membrane-bound
FP aggregates are also probably composed of exten-
sive antiparallel L-sheets exposed to water, given the
similarities between the 12C-FTIR spectra of high-
loaded FP in ghosts and lipid extracts (Figs. 13B
and 14B) with that of FP in PBS (Fig. 2A). Mem-
brane-associated FP at high loading might be a
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loosely bound, surface-located component, perhaps
related to the ¢lamentous, ‘amyloid-like’ structures
observed for N-terminal HIV-1 gp41 peptides in
aqueous media [30]. Alternatively, at high peptide
loading in either ghosts or lipid extracts, deeply in-
serted K-helical FP may aggregate to disrupt the lipid
bilayer and increase the water content, thereby shift-
ing FP from K-helix to extended L-sheet [53]. With
FPG5ÿA15 added to erythrocyte ghosts or lipid ex-
tracts at high loading, the 13C-FTIR spectra demon-
strated a large shift (V38 cm31) from the L-sheet
maximum (V1624^1627 cm31) in the corresponding
12C-FTIR spectra (Figs. 13B and 14B). These 13C-
FTIR spectral ¢ndings argue that FP residues Gly-5
to Ala-15 directly participate in the hydrogen-
bonded, antiparallel L-sheet, and are in accord with
the recent solid-state, 13C-enhanced NMR analysis of
FP bound to mixed liposomes indicating that resi-
dues Ala-1 to Ala-15 are extended L-strands [36].
Also, it should be noted that the 13C-FTIR spectral
shifts for FPG5ÿA15 in erythrocyte ghosts (Fig. 13B)
or lipids (Fig. 14B) are very similar to those reported
in earlier 13C-FTIR spectra of aqueous amyloid pep-
tides [56^58], supporting the hypothesis that the
N-terminal HIV-1 gp41 domain belongs to the prion
class of peptides that form L-sheet amyloid ¢brils
[93,94].
The above 13C-FTIR analysis of FP in POPG lipo-
somes (Figs. 6, 8 and 10) represents a major advance
over past residue-speci¢c investigations, because it
permits direct measurements on peptide structure in
lipid bilayers at physiologically relevant tempera-
tures. For example, most previous residue-speci¢c
physical experiments on FP were limited to organic
solvents (e.g. TFE or HFIP) [43,48,49,51] or deter-
gent micelles [49], and use of these membrane-mimics
may be successful only as a ¢rst approximation in
simulating FP structure in lipid bilayers. One recent
solid-state, 13C-NMR study reported the residue-spe-
ci¢c conformation of FP bound to mixed lipid
vesicles at 350‡C (see above) [36], but it is unclear
whether this peptide structure is maintained at phys-
iologic temperatures. Here, we ¢nd from 13C-FTIR
spectroscopy and molecular modeling of FP in
POPG liposomes that residues 1^16 fold as an K-
helix, with extended L- and random structures (resi-
dues 17^23) having a high degree of £exibility (Figs.
6, 8 and 10). Although earlier residue-speci¢c inves-
tigations on FP in membrane-mimics indicate struc-
tural models that broadly agree with those obtained
from 13C-FTIR spectra of FP in POPG, signi¢cant
‘¢ne-structure’ discrepancies are nevertheless seen.
13C-FTIR spectra of FP in either HFIP (Figs. 4A,
5A and 6) or TFE (Figs. 6 and 7A,B and 9D), as well
as 2D-NMR analysis of FP in SDS or TFE [49],
indicated fraying of the K-helix at the N-terminus,
which is not observed in 13C-FTIR spectroscopy of
FP in POPG liposomes (Fig. 8A). The participation
of the N-terminal residues in the K-helix determined
here for FP in POPG may be relevant in HIV-cell
fusion, since removal of as few as three residues from
the N-terminus of gp41 markedly diminished syncy-
tia formation of CD4 cells transfected with this
deletion mutant [25]. On the other hand, a range of
physical^biochemical techniques con¢rmed that resi-
dues Gly-13, Ala-14, Ala-15 and Gly-16 participate
in the C-terminal cap of the K-helix, regardless of
whether FP is incorporated into membrane-mimics
or bilayer lipids (Figs. 6 and 11) [48^51]. Based on
the 13C-FTIR spectroscopic results and energy min-
imization results presented here, our model for FP in
either the HFIP solvent (Figs. 6 and 11) or POPG
liposomes (Fig. 6) indicates that the carboxyl termi-
nus of the helix is a glycine-based cap at Ala-15
known as the KL motif [95], in which Gly-16 assumes
a left-handed conformation and a single hydrogen
bond occurs between the sN-H at Gly-16 and the
sC = O at Leu-12. Chang et al. [49] proposed that
the residues Ala-15 and Gly-16 lie at the lipid polar
head group^water interface, consistent with previous
¢ndings of deep penetration of the FP K-helix into
the lipid bilayer interior [17]. It is of interest to note
that this C-capping sequence (i.e. Gly-13, Ala-14,
Ala-15, Gly-16) in the N-terminal gp41 peptide is
highly conserved among all known HIV isolates
[64]. Given the large genomic divergence among viral
isolates [64], this well-conserved, K-helical C-cap may
play critical functional roles in HIV processes (e.g.
infection, pathogenesis). Last, it is important to note
that the detailed K-helical structure determined here
for FP in POPG liposomes (Fig. 6) may also occur in
host cell plasma membranes, given our 13C-FTIR
¢ndings of comparable K-helical structures for FP
in RBC ghosts and ghost lipid extracts (Figs. 13A
and 14A).
The residue-speci¢c structures determined here for
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HIV-1 FP may provide further information on how
this gp41 domain participates in viral infection. HIV-
1 entry into cells is a two-step process [96], in which
the virus binds to cell receptors and then promotes
fusion between the opposing lipid bilayers of the vi-
ral envelope and cell surface [18,19]. The binding of
viral gp120 with cell receptors may expose activated
FP [5,97], which may in turn attack the host^cell
surface. Although the conformation and location of
the FP have not been identi¢ed in earlier X-ray dif-
fraction studies of gp41 fragments [10^12,47], this
domain may associate with the host^cell surface
membrane as a trimer. Since the lipid composition
of erythrocyte ghosts is comparable to that of the
lymphocyte plasma membrane [18], the residue-spe-
ci¢c structures detected here (i.e. K-helix or L-sheet)
for FP in ghost membranes (Figs. 13 and 14) may
similarly occur in the host^cell surface, serving as an
anchor to draw the virus to the target cell [38]. An
interesting variation of this ‘prefusion’ model hy-
pothesizes that the activated fusion peptides simulta-
neously bind to both viral and target membranes,
bringing them into close apposition [2]. That FP
could loop back and interact with the HIV-1 enve-
lope by assuming K-helix and/or L-structures as in
erythrocyte ghosts and lipid extracts (Figs. 13 and
14) is suggested by the nearly identical lipid compo-
sitions reported for erythrocyte ghosts and the HIV
envelope [18]. Experimental support for HIV-1 FP
joining the viral envelope and targets cells comes
from our earlier results showing that synthetic FP
is a potent erythrocyte-aggregating agent [38,42,43].
Besides its role in aggregating the viral envelope with
host cells, the N-terminal domain of gp41 may also
be more directly involved in perturbing membranes
critical for HIV-1 infection. As indicated in Section
1, synthetic peptides based on the N-terminal domain
of gp41 induce leakage and/or fusion of not only
model liposomes [27^35,39^41] but also human
erythrocytes and CD4 lymphocytes [37,42].
Although there is no generally accepted model for
how HIV-1 fusion peptides induce their cytolytic
and fusogenic activities, earlier work has indicated
possible roles for the deep insertion of peptides
into lipid bilayers [17,28,35,49], oblique intercalation
of K-helical peptide into membrane lipids [31,39,98,
99], membrane aggregation of peptides [17,40, 53],
formation of membrane-associated peptide in L-con-
formations [17,32,33,36,53], peptide induction of
non-bilayer lipid [100^102], or creation of peptide-
membrane pores [2,53,96]. It is of particular interest
that sequence modi¢cations in the N-terminal gp41
domain reduced HIV infectivity and syncytia forma-
tion in prior site-directed mutagenesis experiments,
and these alterations similarly blunted peptide-in-
duced lysis and fusion with either red cells [42,43]
or model liposomes [27,33,35,39,40]. Future applica-
tion of residue-speci¢c techniques (e.g. 13C-FTIR or
ESR spectroscopy of spin-labeled peptides) to these
fusion-defective FP variants may indicate whether
the detailed conformations determined here, or if
any of the above proposed mechanisms of action,
for FP play a role in membrane perturbations.
The results obtained here on HIV-1 FP indicate
that the joint use of 13C-FTIR spectroscopy and en-
ergy minimizations will be of general utility in map-
ping the secondary structures of peptides and pro-
teins, especially in membrane environments that
have been di⁄cult to characterize with X-ray crystal-
lography or 2D-NMR spectroscopy. FTIR analysis
of peptides substituted with 13C-labeled carbonyls is
a non-perturbing methodology that permits direct
assessment of local peptide conformations in mem-
brane-mimics, lipids and membranes. In previous ex-
periments [63], 13C-FTIR spectroscopy has been
combined with energy minimizations and molecular
simulations to provide an amino acid resolution
model of SP-B1ÿ25 in POPG lipid, which speci¢ed
locations for L-sheet, K-helix and random conforma-
tions (PDB accession code: 1DFW). In the present
work, we ¢nd from 13C-FTIR spectroscopy and en-
ergy minimizations of FP in HFIP solvent that resi-
dues 3^16 fold as an K-helix, with extended L- and
random structure residues (1^2 and 17^23) having a
high degree of £exibility (PDB accession code:
1ERF) (Figs. 6 and 11A,B). Similar studies indicated
a model for FP in POPG (Fig. 6) nearly identical to
that for FP in HFIP (Fig. 11A,B), except that resi-
dues Ala-1 and Val-2 also participate in the K-helix.
We anticipate that analogous residue-speci¢c, 13C-
enhanced FTIR spectroscopy and energy minimiza-
tions may also elucidate the structures of other lipid
bilayer-bound proteins and peptides. Such analyses
could greatly assist ongoing structural genomics proj-
ects which aim to yield a complete set of protein
folds [103], particularly since V20^30% of the hu-
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man genome codes for membrane proteins [104], but
few membrane-bound proteins have been structurally
determined [103]. Also of interest is our ¢nding that
the conformation of the core region of FP may be
elucidated in such biological membranes as erythro-
cytes using heavily 13C-labeled peptides (Figs. 13 and
14). This technique is an extension of previous 13C-
FTIR experiments using proteins that were uni-
formly labeled with 13C-carbonyls (i.e. ‘isotope-
edited’) to examine the secondary structure in both
protein^peptide [105] and protein^protein [106] com-
plexes. Our results indicate that this 13C-FTIR meth-
odology may provide unique, residue-speci¢c infor-
mation on other protein and peptide conformations
in biomembranes.
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